CLI:MILCentrale del Latte d'Italia S.p.A. Analysis
Data as of 2026-03-11 - not real-time
€4.50
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Centrale del Latte d'Italia trades at €4.50, comfortably below its 20‑day (€4.86) and 50‑day (€4.93) moving averages, signaling short‑term weakness, while remaining above the 200‑day average, indicating a longer‑term base. RSI at 36 points to oversold conditions, yet the MACD histogram stays negative, suggesting bearish momentum persists. The stock’s valuation appears attractive: a PE of ~13 and PB of 0.81 are well under industry norms, and the discounted cash‑flow model implies a fair value near €31, translating to a theoretical upside of over 30% versus the current price. However, the company’s fundamentals show modest revenue growth (≈1%), thin profit margins (≈1.4%), and a high debt‑to‑equity ratio of ~116%, raising concerns about financial resilience.
Market sentiment is buoyant, reflected by an “Extreme Greed” index, and trading volume is on the rise, yet volatility remains elevated at roughly 46% and beta hovers near zero, indicating price swings are driven more by company‑specific factors than broader market moves. The absence of a dividend further limits income‑focused appeal, positioning the stock primarily as a value play for investors willing to tolerate the operational and leverage risks.
Market sentiment is buoyant, reflected by an “Extreme Greed” index, and trading volume is on the rise, yet volatility remains elevated at roughly 46% and beta hovers near zero, indicating price swings are driven more by company‑specific factors than broader market moves. The absence of a dividend further limits income‑focused appeal, positioning the stock primarily as a value play for investors willing to tolerate the operational and leverage risks.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support at €4.32
- RSI indicating oversold conditions
- Bearish MACD momentum despite rising volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation upside implied by DCF and low PE/PB
- Stable consumer‑defensive sector with low cyclicality
- Forward EPS guidance shows improving earnings
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High leverage and thin profit margins limit upside
- No dividend payout reduces total return potential
- Long‑term sector stability offsets operational risks
Key Metrics & Analysis
Financial Health
Revenue Growth1.10%
Profit Margin1.35%
P/E Ratio12.9
ROE6.33%
ROA2.05%
Debt/Equity115.93
P/B Ratio0.8
Op. Cash Flow€35.8M
Free Cash Flow€29.6M
Technical Analysis
TrendNeutral
RSI35.9
Support€4.32
Resistance€5.30
MA 20€4.86
MA 50€4.93
MA 200€3.92
MACDBearish
VolumeIncreasing
Fear & Greed Index76.64
Valuation
Fair Value€30.91
Target Price€6.00
Upside/Downside33.33%
GradeUndervalued
TypeValue
Risk Assessment
Beta-0.09
Volatility46.47%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.